A Single-Dose, Randomized, Open-Label, 2-Way Crossover, Comparative Bioavailability Study of BLS-11 (Monomethyl Fumarate) 190 mg and Tecfidera (Dimethyl Fumarate) 240 mg in Healthy Male and Female Subjects Under Fasting Conditions
Latest Information Update: 02 Nov 2021
At a glance
- Drugs Citraconic acid (Primary) ; Dimethyl fumarate
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- Sponsors Banner Life Sciences
- 30 Mar 2021 Primary endpoint (The BE comparison of Cmax of MMF between treatments) , has been met according to Results published in the CNS Drugs
- 30 Mar 2021 Primary endpoint (The bioequivalent (BE) comparison of AUC0-inf of MMF between treatments) , has been met according to Results published in the CNS Drugs
- 30 Mar 2021 Results published in the CNS Drugs